SEC Form 4 · accession 0001140361-16-066056
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
May 16, 2016
Accepted (ET)
May 17, 2016 · 6:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | May 16, 2016 | M | 5,975 | $33.70 | A | 154,723 | D | |
| ResMed Common StockF3 | May 16, 2016 | S | 5,975 | $57.635 | D | 148,748 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $33.70 | May 16, 2016 | M | 5,975 | D | Nov 11, 2011 | Nov 11, 2017 | ResMed Commmon Stock | 5,975 | 33,175 | D |
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 plan.
- F2Represents date options first became exercisable. Options vest 1/4 per year.
- F3This transaction was executed in multiple trades at prices ranging from $57.50 to $57.81. The price reported above reflects the weighted average sale price.